相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格: | 1 mg | 产品价格: | ¥400.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥1000.0 |
| 规格: | 10 mg | 产品价格: | ¥1500.0 |
| 规格: | 25 mg | 产品价格: | ¥2700.0 |
| 规格: | 50 mg | 产品价格: | ¥4050.0 |
| 规格: | 100 mg | 产品价格: | ¥6000.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CVT-12012
CAS No. : 1018675-35-8
MCE 国际站:CVT-12012
产品活性:CVT-12012 是一种有效的、具有口服活性的硬脂酰-CoA 去饱和酶 (SCD) 的抑制剂,其对大鼠微粒体和人 HEPG2 的 IC50 值分别为 38 nM,6.1 nM。
研究领域:Metabolic Enzyme/Protease
作用靶点:Stearoyl-CoA Desaturase (SCD)
In Vitro: CVT-12012 (Compound 5b) displays the highest potency in both the microsomal and the HEPG2 SCD assays (IC50 38 nM and 6.1 nM, respectively) compared to the other methyl-substituted compounds.
In Vivo: In a rat PK study, CVT-12012 demonstrates good oral bioavailability (78%). It appears that the oral absorption of CVT-12012 is not affected by a significant Pgp efflux, which is expected based on Caco-2 assay result. The plasma clearance of CVT-12012 is high (88 mL/min/kg) with elimination half-life of approximately 1 h.
相关产品:Bioactive Compound Library Plus | Metabolism/Protease Compound Library | Orally Active Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Obesity Compound Library | Lipid Metabolism Compound Library | A939572 | CAY10566 | Icomidocholic acid | MK-8245 | MF-438 | PluriSIn 1 | GSK1940029 | E6446 dihydrochloride | Elemicin | XEN723 | SCD1 inhibitor-1 | SCD1 inhibitor-4 | SCD1 inhibitor-3 | YTX-465 | CVT-11127 | SSI-4 | Sterculic acid | T-3764518 | SCD1/5-IN-1 | SCD1-IN-1
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















